Sign In
Buy CRMD
$8.23
+0.0600 (+0.734%)
At Close: Jun 03, 2026
Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings
12:00am, Wednesday, 16'th May 2018BRIEF-Cormedix Reports Q1 Loss Per Share $0.14
10:36pm, Tuesday, 15'th May 2018
* Q1 LOSS PER SHARE $0.14 Source text : (https://bit.ly/2Iju3BO) Further company coverage:
CorMedix's (CRMD) CEO Khoso Baluch on Q1 2018 Results - Earnings Call Transcript
12:00am, Tuesday, 15'th May 2018BRIEF-Cormedix Qtrly Loss Per Share $0.15
09:00pm, Monday, 19'th Mar 2018
* CORMEDIX INC - AT DEC 31, 2017, CO HAD $12.0 MILLION IN CASH AND SHORT-TERM INVESTMENTS
CorMedix Reports Q4 EPS $(0.15) Misses $(0.12) Est., Sales $92.53K Misses $100K; Shares Down 6.6% After Hours
12:00am, Monday, 19'th Mar 2018BRIEF-Cormedix Inc Files For Mixed Shelf Of Up To $70 Million
10:41pm, Friday, 09'th Mar 2018
* CORMEDIX INC FILES FOR MIXED SHELF OF UP TO $70 MILLION - SEC FILING Source text (http://bit.ly/2DeRiWo) Further company coverage:
CorMedix Gets Orphan Drug Designation for Taurolidine from the FDA
12:00am, Friday, 23'rd Feb 201819 Biotech Stocks With Clinical Trial Outcomes In February
12:00am, Thursday, 08'th Feb 2018CorMedix Drug Candidate Lauded By FDA, Approved In The EU, Could Treat Deadly Pathogen Feared By CDC
12:00am, Friday, 02'nd Feb 2018BRIEF-Cormedix Amends Registration Rights Agreement
02:49pm, Monday, 11'th Dec 2017
* CORMEDIX SAYS ENTERED AMENDMENT TO REGISTRATION RIGHTS AGREEMENT BY AND BETWEEN CO, ELLIOTT ASSOCIATES LP, ELLIOTT INTERNATIONAL LP - SEC FILING
